Newsroom
Virometix secures USD 15 million to advance novel pneumococcal vaccine
13.11.2025
Schlieren-based Virometix, a biotechnology company developing fully synthetic vaccines designed to generate targeted immune respon ... more
Autonomyo secures EUR 1.4 million and launches crowdfunding to scale safe home rehabilitation
13.11.2025
Renens-based Medtech startup Autonomyo, founded at EPFL, has raised EUR 1.4 million from private and public investors and launched ... more
CASUS exits CASUS Create in LAWLIFT deal
13.11.2025
Swiss Legal Tech company CASUS has sold its CASUS Create business line to German document automation provider LAWLIFT. The move al ... more
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
